Alternative Complement Pathway Inhibition With Iptacopan for the Treatment of C3 Glomerulopathy-Study Design of the APPEAR-C3G Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Alternative Complement Pathway Inhibition With Iptacopan for the Treatment of C3 Glomerulopathy-Study Design of the APPEAR-C3G Trial

Published:2022-10 Issue:10 Volume:7 Page:2150-2159
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Bomback Andrew S.,Kavanagh David,Vivarelli Marina,Meier Matthias,Wang Yaqin,Webb Nicholas J.A.,Trapani Angelo J.,Smith Richard J.H.

Funder

Novartis

National Institutes of Health

Publisher

Elsevier BV

Subject

Nephrology

Reference41 articles.

1. C3 glomerulopathy - understanding a rare complement-driven renal disease;Smith;Nat Rev Nephrol,2019

2. Update on C3 glomerulopathy: a complement-mediated disease;Caravaca-Fontán;Nephron,2020

3. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies;Servais;Kidney Int,2012

4. Genetics of immune-mediated glomerular diseases: focus on complement;Noris;Semin Nephrol,2017

5. Unraveling the molecular mechanisms underlying complement dysregulation by nephritic factors in C3G and IC-MPGN;Donadelli;Front Immunol,2018

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First Successful Treatment of a Patient with a Primary Immune Complex-Membranoproliferative Glomerulonephritis with Iptacopan: A Case Report;Case Reports in Nephrology and Dialysis;2024-08-07

2. IgA Nephropathy: Emerging Mechanisms of Disease;Indian Journal of Nephrology;2024-06-24

3. Updates on C3 Glomerulopathy in Kidney Transplantation: Pathogenesis and Treatment Options;International Journal of Molecular Sciences;2024-06-13

4. Developing Therapies for C3 Glomerulopathy;Clinical Journal of the American Society of Nephrology;2024-06-03

5. Factor B Inhibition with Iptacopan in Recurrent C3 Glomerulopathy Following Kidney Transplant: A Report of Two Cases;Kidney Medicine;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3